Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VIA Equity Fund III K/S invests in GleSYS AB and Portlane AB
Mandate

VIA Equity Fund III K/S invests in GleSYS AB and Portlane AB

May 08, 2018 IT, Telecommunications and Outsourcing

Vinge has advised VIA Equity Fund III K/S, together with the current owners, founders and CEO Glenn Johansson, in connection with the investment in GleSYS AB and Portlane AB through a new, jointly owned, holding structure.

GleSYS and Portlane offer services within colocation, dedicated servers, network and connections, system management and virtual private servers. The companies’ joint turnover is approximately SEK 100 million with good profitability.

Vinge’s team consisted primarily of Johan Winnerblad, Alex Miler, Andrea Ahlgren, Marith Welin-Berger and Viktor Wahlqvist.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026